Chugai Pharmaceutical is one of Japan’s leading research-based pharmaceutical companies with strengths in biotechnology products. Chugai, based in Tokyo, specializes in prescription pharmaceuticals and is listed on the 1st section of the Tokyo Stock Exchange. As an important member of the Roche Group, Chugai is actively involved in R&D activities in Japan and abroad. Specifically, Chugai is working to develop innovative products which may satisfy the unmet medical needs, mainly focusing on the immunology and oncology areas.
Chugai’s founding spirit of “Creating drugs that benefit the world” remains deeply firmly rooted as our integral business philosophy “Innovation all for the patients” in our culture today. We look back over 90 years history that Chugai overcame a number of challenging times to always pursue its core businesses and technologies.